Pulse Biosciences, Inc.

FDA Regulatory Profile

Pulse Biosciences, Inc. appears in FDA public data with 0 recalls, 7 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on August 5, 2024.

Summary

Total Recalls
0
510(k) Clearances
7
Inspections
0
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K240782CellFX Percutaneous Electrode System (SYS3000); CellFX Percutaneous Electrode, 13G (CPE013); CellFX August 5, 2024
K233705CellFX Percutaneous Electrode System (SYS3000)March 8, 2024
K213674CellFX SystemSeptember 22, 2022
K222075CellFX SystemSeptember 2, 2022
K221671CellFX® SystemAugust 1, 2022
K211444CellFX SystemAugust 25, 2021
K203299CellFX SystemFebruary 2, 2021